chairman letter

1/ OPES ISSUE: We are already taking very specific
action on a number of fronts.I would like to personally assure you that any action taken by either Solagran or Solamind in
this matter will be done with the interests of all shareholders in mind – be they big or small.

2/Sale of BIOEFFECTIVE@A is up 83% (Mar08 vs Dec07)

3/ Production of BioEffective@R: commercial production facility is completed in Tomsk and is now in the
process of making the first commercial quantity of Bioeffective® R.


http://www.aspectfinancial.com.au/docserver/00828990.pdf?fileid=00828990&datedir=20080403&edt=MjAwOC0wNC0xNysyMToxMTozMSsxMjArNjMwNjY1MzMrZXRyYWRleG1sK3JlZGlyZWN0Ky9pbWFnZXNpZ25hbC9lcnJvcnBhZ2VzL0V0cmFkZVBERlRpbWVvdXQuaHRtbCsvaW1hZ2VzaWduYWwvZXJyb3JwYWdlcy9wZGZkZWxheWVkLmpzcA==&popup=true